Ipsen S.A. (IPSEY)
| Previous close | 30.81 |
| Open | 30.92 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 30.81 - 30.81 |
| 52-week range | 26.97 - 34.34 |
| Volume | |
| Avg. volume | 1,601 |
| Market cap | 10.193B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 15.48 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.32 (1.04%) |
| Ex-dividend date | 02 Jun 2023 |
| 1y target est | N/A |
- Globe Newswire
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
Information relating to the holding of the Combined Shareholders’ Meeting of 28 May 2024 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting BOULOGNE-BILLANCOURT, FRANCE, 7 May 2024 - The Shareholders of the Company are invited to participate in the Combined Shareholders’ Meeting of Ipsen (Euronext: IPN; ADR: IPSEY) to be held on Tuesday 28 May 2024 at 3:00 p.m. (Paris time) at the Salons de l'Hôtel des Arts et Métiers, 9 bis avenue d'Iéna, 75116 Pa
- Globe Newswire
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 Date Total number of shares composing the share capital Total number of voting rights (1) 30 April 2024 83,814,526 Gross total* of voting rights: 132,102,659 Net total*
- GlobeNewswire
Ipsen appoints Keira Driansky as EVP, President of North America
PARIS, FRANCE, 2 May 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the Executive Leadership Team (ELT) and report directly to Ipsen’s Chief Executive Officer (CEO), David Loew. “We are thrilled to welcome Keira to Ipsen as our new President of North America as she brings extensive experience in the life sciences industry
